Over the past decade, kratom has moved from relative obscurity to widespread availability across the United States. Often marketed as a “natural” solution for pain, anxiety, or opioid withdrawal, kratom products are now sold in gas stations, vape shops, and online marketplaces with limited regulatory oversight.
Although many consumers assume kratom is harmless, clinicians, treatment providers, and families with firsthand experience increasingly recognize it as a growing public health concern.
At S2L Recovery, we believe it is essential to stay ahead of emerging substance trends rather than responding only after harm occurs. As a Christ-centered, licensed, and Joint Commission–accredited treatment organization, we are committed to understanding substances like kratom, addressing the risks they present, and helping individuals find lasting freedom from addiction.
For this reason, we support Tennessee House Bill 1649, which seeks to address the growing availability and potency of kratom products while strengthening protections for public health.
What Is Kratom?
Kratom (Mitragyna speciosa) is a tropical tree native to Southeast Asia whose leaves contain alkaloids that interact with the brain’s opioid receptors.
- At lower doses, kratom can produce stimulant-like effects such as increased energy and alertness.
- At higher doses, it can produce sedation, pain relief, and euphoria similar to opioids.
Because kratom is frequently marketed as a dietary supplement rather than a pharmaceutical drug, many individuals assume it is safe or non-addictive. However, emerging research and clinical experience suggest otherwise. Regular use may lead to:
- Physical dependence
- Withdrawal symptoms upon discontinuation
- Mood disturbances and anxiety
- Cognitive impairment
- Increased risk when combined with other substances
For some individuals, kratom becomes another pathway into opioid-like dependence.
Rising Concerns Over High-Potency Kratom Products
Public health officials have raised concerns about increasingly potent kratom formulations, particularly products containing 7-hydroxymitragynine (7-OH)—a concentrated compound that strongly activates opioid receptors.
These highly concentrated products may significantly increase the risk of addiction and severe withdrawal symptoms. As kratom products continue to proliferate in vape shops and retail outlets, many experts warn that the United States may once again be witnessing the early stages of another substance-related public health challenge.
The rapid commercialization of these products—often without standardized labeling, dosage controls, or safety testing—has intensified calls for greater regulatory oversight.
Why Treatment Providers Are Paying Attention
Kratom dependence presents several challenges that treatment providers are encountering with increasing frequency:
- Limited regulatory oversight can lead to inconsistent potency and potential contamination
- Public misperceptions of safety often delay individuals from seeking treatment
- Withdrawal symptoms may include anxiety, agitation, nausea, insomnia, depression, and intense cravings
- Polysubstance use is common, with kratom frequently used alongside opioids, alcohol, or benzodiazepines
These factors make kratom dependence more complex than many people initially assume.
Considerations for Individuals Already Dependent on Kratom
Reducing access to substances with addictive potential may help prevent new cases of dependency. However, as treatment providers, we also recognize an important clinical concern.
Many individuals who regularly use kratom have already developed opioid receptor dependence. If kratom suddenly becomes unavailable without adequate treatment support, some individuals may seek to manage withdrawal by turning to other opioids.
In the current illicit opioid landscape, that risk is significant. Illicit opioids frequently contain fentanyl, a synthetic opioid associated with extremely high overdose risk.
For this reason, regulatory action should also be accompanied by greater public awareness and expanded treatment resources to help individuals safely transition away from dependence.
S2L Recovery’s Integrated Approach
Since 2006, S2L Recovery has provided a comprehensive model of care that addresses addiction at the physical, emotional, relational, and spiritual levels.
Under the leadership of CEO Adam Comer, S2L combines licensed clinical treatment, medical oversight, and Christ-centered discipleship within a structured recovery community.
Importantly, S2L Recovery has been successfully treating individuals struggling with kratom dependency for nearly a decade—well before kratom became widely recognized in the broader public conversation about addiction. Through years of clinical experience, S2L’s medical leadership has developed specialized protocols designed to address the unique challenges associated with kratom dependence.
S2L Recovery’s Medical Director has established an effective Kratom detoxification protocol that is implemented within the organization’s in-house medical detox program, allowing individuals to safely and as comfortably and safely as possible discontinue kratom use under professional supervision.
Following detoxification, individuals transition into S2L Recovery’s inpatient recovery program, where they begin the deeper work of healing. This phase focuses on addressing the mental, emotional, and spiritual factors that often contribute to substance use, helping individuals develop the tools, support systems, and renewed sense of purpose necessary for long-term recovery.
Our approach includes:
- Individualized detox and withdrawal management, including kratom-specific protocols
- Evidence-based clinical counseling addressing trauma and mental health
- Christ-centered discipleship and spiritual formation
- Long-term recovery planning that supports lasting transformation
Hope and Recovery
If you or someone you love is struggling with kratom or another substance, S2L Recovery is ready to walk alongside you with clinical excellence, faith, and unwavering hope.
Freedom is possible. Healing is possible. Restoration is possible.
